These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Clinical experience in human diabetics with portable and implantable insulin minipumps. Mirouze J; Selam JL; Slingeneyer A; Chaptal PA; Hedon B; Mares P; Franetzki M; Prestele K; Millet P; Beraud JJ Life Support Syst; 1983; 1(1):39-49. PubMed ID: 6678370 [TBL] [Abstract][Full Text] [Related]
9. Stability of cancer chemotherapeutic agents in a totally implanted drug delivery system. Keller JH; Ensminger WD Am J Hosp Pharm; 1982 Aug; 39(8):1321-3. PubMed ID: 6214944 [TBL] [Abstract][Full Text] [Related]
10. Patient-controlled analgesia in chronic pain patients: experience with a new device designed to be used with implanted programmable pumps. Ilias W; le Polain B; Buchser E; Demartini L; Pain Pract; 2008; 8(3):164-70. PubMed ID: 18384501 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of a readily-fabricated infusion device. Wang PY; Smith MS Life Support Syst; 1987; 5(2):95-109. PubMed ID: 3669726 [TBL] [Abstract][Full Text] [Related]
12. Novel drug delivery systems in pain therapy. Al Malyan M; Becchi C; Boncinelli S; Ashammakhi N Minerva Anestesiol; 2007 Mar; 73(3):173-9. PubMed ID: 17159768 [TBL] [Abstract][Full Text] [Related]
13. Protein delivery with infusion pumps. Bremer U; Horres CR; Francoeur ML Pharm Biotechnol; 1997; 10():239-54. PubMed ID: 9160375 [TBL] [Abstract][Full Text] [Related]
14. Potential new drug delivery systems for antidepressants: an overview. Kilts CD J Clin Psychiatry; 2003; 64 Suppl 18():31-3. PubMed ID: 14700453 [TBL] [Abstract][Full Text] [Related]
15. Current status and future of implantable insulin pumps for the treatment of diabetes. Catargi B Expert Rev Med Devices; 2004 Nov; 1(2):181-5. PubMed ID: 16293038 [TBL] [Abstract][Full Text] [Related]
16. [From external to implantable insulin pump, can we close the loop?]. Renard E; Costalat G; Bringer J Diabetes Metab; 2002 Sep; 28(4 Pt 2):2S19-2S25. PubMed ID: 12442060 [TBL] [Abstract][Full Text] [Related]
17. Development of remotely controlled implantable devices for programmed insulin infusion. Prestele K; Funke H; Möschl R; Reif E; Franetzki M Life Support Syst; 1983; 1(1):23-38. PubMed ID: 6379315 [TBL] [Abstract][Full Text] [Related]
18. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
19. [Clinical experience of a subcutaneously implantable drug delivery catheter (PORT-A-CATH)]. Kimura K; Koide A; Suga S; Shimoyama T; Okamoto E; Utsunomiya J; Okawa T; Taguchi T; Wakui A Gan To Kagaku Ryoho; 1987 Apr; 14(4):1150-5. PubMed ID: 3566308 [TBL] [Abstract][Full Text] [Related]
20. Use of an implantable drug delivery system for refractory chronic sickle cell pain. Smith TJ; Coyne PJ; Smith WR; Roberts JD; Smith V Am J Hematol; 2005 Feb; 78(2):153-4. PubMed ID: 15682408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]